The Supreme Court of the United States’s (SCOTUS’s) unanimous decision in Food and Drug Administration v. Alliance for Hippocratic Medicine (FDA v. AHM) on June 13, 2024, articulated a much more absolute view of the protections federal law affords to individual healthcare provider personnel to refuse to participate in the provision of certain healthcare for personal conscience reasons than has ever previously been articulated in the text, legislative history or judicial interpretation of the relevant federal statutes. That aspect of SCOTUS’s decision may lead to a significant uptick in the number of conscience-based opt-out requests that healthcare provider organizations receive from members of their workforces (e.g., physicians, nurses), while simultaneously making each such request more difficult to address without significant cost or liability exposure.
Please see full publication below for more information.
